Pdt Partners, LLC Karyopharm Therapeutics Inc. Transaction History

Pdt Partners, LLC

  • $1.02 Billion
  • Q3 2024

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2022

Aug 15, 2022
SELL
$4.15 - $8.37 $85,257 - $171,953
-20,544 Reduced 66.75%
10,234 $46,000
Q1 2022

May 16, 2022
BUY
$5.91 - $14.38 $181,897 - $442,587
30,778 New
30,778 $227,000
Q2 2021

Aug 16, 2021
SELL
$8.11 - $11.11 $576,020 - $789,098
-71,026 Closed
0 $0
Q1 2021

May 17, 2021
BUY
$9.85 - $17.69 $699,606 - $1.26 Million
71,026 New
71,026 $747,000

Others Institutions Holding KPTI

# of Institutions
98
Shares Held
57.6M
Call Options Held
258K
Put Options Held
81.2K
View Full List

About Karyopharm Therapeutics Inc.

KPTI Quotes by TradingView
  • Ticker KPTI
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 79,806,600
  • Market Cap $55.9M
  • Description
  • Karyopharm Therapeutics Inc., a commercial-stage pharmaceutical company, discovers, develops, and commercializes drugs directed against nuclear export for the treatment of cancer and other diseases. The company discovers, develops, and commercializes novel and Selective Inhibitor of Nuclear Export (SINE) compounds function by binding with and in...
More about KPTI
Track This Portfolio

Track Pdt Partners, LLC Portfolio

Follow Pdt Partners, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Pdt Partners, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Pdt Partners, LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email